Replies to post #140023 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

You need to read the OWCP 10-K - they state very clearly they are a target of a SEC investigation.

"We may expend a substantial amount of time and resources in connection with SEC or stockholder-related inquiries or legal actions related to an ongoing investigation by the SEC.

March 2018, we received a non-public subpoena dated February 16, 2018 issued by the SEC ordering the provision of documents and related information concerning certain of the issues involved in the Friedland Matter. We are in a process of responding to the subpoena and intend to fully cooperate with the SEC. We are unaware of and unable to predict the length, scope, outcome or impact of the SEC’s investigation. As a result, we do not know how the SEC investigation is proceeding, when the investigation will be concluded, or if we will become involved to a greater extent than merely responding to the subpoena we received. This may become a material cost to us, distract the time and attention of our officers and directors or divert our resources away from ongoing research and development programs and result in loss of investor confidence and a decline in price of our Common Stock."

If OWCP isn't the target of the investigation why would they need to - "We may expend a substantial amount of time and resources in connection with SEC or stockholder-related inquiries or legal actions related to an ongoing investigation by the SEC."

If OWCP is just turning over records to the SEC why would it take a substantial amount of resources?

Or - "or legal actions related to an ongoing investigation by the SEC"

The SEC rarely states publicly that a investigation is ongoing as they did with Friedland/OWCP.

Then OWCP posted the SEC investigation as a Material Event in the 10-K.

IG